BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20200308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20201101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20210314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20211107T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20210811T083000
DTEND;TZID=America/Denver:20210811T130000
DTSTAMP:20260426T032551
CREATED:20210610T010945Z
LAST-MODIFIED:20210610T010945Z
UID:2014-1628670600-1628686800@thebiocalendar.com
SUMMARY:PBSS Free Online Workshop: Advances in Immuno-Oncology
DESCRIPTION:The last few years has seen major advancements in cancer treatment through immunotherapy. This symposium aims to provide a comprehensive overview of the emerging concepts in cancer immunotherapy from the latest biologic insights in academia and the latest clinical data for approved and investigational immuno-oncology agents from key biotech and pharmaceutical companies. We will discuss the latest partnership trends and business development efforts in this rapidly evolving landscape.  \nTopics to be covered: \nTumor-targeting immune stimulating antibody conjugates\nAdenosine inhibition through A2R blockade and CD73 inhibition\nLeukocyte Immunoglobulin-Like Receptors (LILRs)\nTumor-targeting immune stimulating antibody conjugates\nMYC oncogene in regulating tumor microenvironment\nRas oncogene in regulating tumor microenvironment\nEngineered IL-12\nIL-1RAP mAb\nTavo (DNA-based IL-12)-EP (electroporation) gene-delivery\nBusiness Development landscape for immuno-oncology\nAnd More
URL:https://thebiocalendar.com/event/pbss-free-online-workshop-advances-in-immuno-oncology/2021-08-11/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/PBSS-logo-SFBayai-1-1.jpg
END:VEVENT
END:VCALENDAR